Impact of Home Zinc Treatment for Acute Diarrhea in Children

Last updated: March 8, 2010
Sponsor: Centers for Disease Control and Prevention
Overall Status: Completed

Phase

3

Condition

Lactose Intolerance

Bowel Dysfunction

Colic

Treatment

N/A

Clinical Study ID

NCT00530829
CDC-NCPDCID-4678
  • Ages 2-4
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Background. Zinc deficiency is common in Africa. It has been shown in Asia that zinc as treatment for diarrhea can shorten the course of episodes of diarrhea, as well as prevent future episodes. The use of zinc at home to treat diarrhea in an African setting, where malaria, HIV and malnutrition are common, has not been well-studied.

Objective. To evaluate if zinc treatment for diarrhea given at home in Kenyan children will decrease the community prevalence of diarrhea more than zinc given only in the clinic Work planned. We propose to do a community-randomized intervention study of 10 days of dispersible zinc tablets given in the home, in addition to ORS, to treat diarrhea in children under-5 years of age living in a rural part of Bondo District. The comparison group will be children who receive zinc and ORS in the clinic only. The primary outcome will be a comparison of the prevalence of diarrhea in home zinc versus nonhome zinc villages. Secondary outcomes will be the incidence of repeat episodes of diarrhea, the duration of diarrheal illness, the prevalence of acute respiratory infection, and the effect of malaria infection on treatment with zinc. Thirty-three villages (approximately 1300 children) will be enrolled and children will be followed for 1 year.

Significance of results. If this study shows zinc given at home to be effective, this might be considered by the Kenyan MOH as an essential component of the treatment of diarrhea in children at the community level.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All children 2 to 59 months of age in households within 33 selected villages

Exclusion

Exclusion Criteria:

  • Children under 2 months of age will not be eligible for enrollment, until they reach 2months of age as the role of zinc has not been well-studied in neonates. Children ofparents who do not give written informed consent for their participation will not beenrolled.

Study Design

Total Participants: 3000
Study Start date:
October 01, 2007
Estimated Completion Date:
April 30, 2009

Connect with a study center

  • Kenya Medical Research Institute

    Kisumu,
    Kenya

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.